A Multicenter Study of Artificial Intelligence Model for Fetal Congenital Heart Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorBeijing Anzhen Hospital
About this trial
This study addresses congenital heart disease in fetuses, a specific birth defect, by collaborating with multicenter medical institutions across China. It prospectively collects echocardiographic screening, diagnostic images, and structured parameter data from both normal and abnormal fetuses. Cases are followed up, and artificial intelligence (AI) models are developed to extract fetal heart echocardiographic image features and analyze the data. This process allows for the analysis of the AI models' accuracy, sensitivity, and specificity, and verifies the application value of AI models in fetal heart echocardiographic screening and diagnosis.
Eligibility criteria
Qualifiers
Single or multiple pregnancy;
Gestational age 16-40 weeks;
Fetal echocardiographic images are clear and complete;
Clinical data are complete and detailed;
Disqualifiers
Fetal echocardiographic images are incomplete or of poor quality that cannot be used for research;
Refusal or loss of follow-up
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov